OPK Financial Facts

Loss before income taxes and investment loss: -34.15M
Research and development: 24.42M
See Full Income Statement

Accumulated deficit: -716.29M
Additional paid-in capital: 2.83B
See Full Balance Sheet

Opko Health (OPK) Earnings

  |   Expand Research on OPK
Next EPS Date 1/28/22 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +107.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -3.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/8/18 Q118 -$0.08-$0.13 +$0.05$254.9M$236.9M N/A Details
11/9/18 Q318 -$0.05-$0.08 +$0.03$249.8M$264.04M N/A Details
11/9/15 Q315 $0.25-$0.02 +$0.27$143M$132.99M N/A Details
3/1/18 Q417 -$0.38-$0.08 -$0.30$193.7M$301.4M = Details
8/8/17 Q217 -$0.04-$0.05 +$0.01$314.2M$322.64M = Details
5/11/15 Q115 -$0.26-$0.08 -$0.18$30.1M$23.13M N/A Details
10/28/21 Q321 $0.04-$0.01 +$0.05$385.8M$302.27M N/A Details
5/9/16 Q116 -$0.02-$0.03 +$0.01$291M$266.3M N/A Details